Update in Oncology

Presented by

Target Audience

Primary Care Physicians

Price
$20.00

Program Description
This CME activity consists of an educational component (slides, audio lecture) in an electronic format, followed by an online post-test. Estimated time to complete this activity, including review of materials, is one hour.

Requirements for Successful Completion

• This CME activity consists of an educational component (slides, audio lecture in an electronic format, which is followed by an online post-test).
• Certificates are awarded upon successful completion (80% proficiency) of the post-test.
• In order to receive credit, participants must view the presentation in its entirety.
• The University of Florida College of Medicine will report CME credit to CE Broker when applicable.

Learning Objectives
As a result of participation in this activity, participants should be able to:

1. Relate differences between traditional cytotoxic chemotherapy and biologic agents used in oncology
2. Identify common side effects of tyrosine kinase inhibitors
3. Recognize the role of the immune system in tumor growth
4. Identify new biologic agents approved to treat malignancy

Faculty Disclosure
Dr. Close has disclosed that she has no relevant financial relationships.  No one else in a position to control the content of this activity has any financial relationships to disclose.

Continuing Medical Education Credit
Accreditation: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit: The University of Florida College of Medicine designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Release Date: February 5, 2016

Expiration Date: February 4, 2017